An Alternative Treatment For Blood Clots In The Leg
All anti-coagulants can lead to bleeding or hemorrhaging, such as Pradaxa, but others have antidotes that can reverse the effects of the drug. Many studies have located that there are improved bleeding dangers in Xarelto users, and many FDA Adverse Event Reports state that there have been situations of severe bleeding and even death. The FDA issued its most significant warning, called a black box warning,” warning that those who abruptly cease taking Xarelto and do not replace it with an additional blood thinning medication are at an elevated danger of stroke. Individuals who think they have been harmed by Xarelto side effects can elect to file a lawsuit against J&J.\n\nXarelto use was expanded in November 2011 to lessen stroke and blood clot risks in sufferers with atrial fibrillation (irregular heart rhythms). A Florida lady filed a Xarelto side effects lawsuit in June that alleges her husband died right after suffering a subdural hemorrhage. According to the Xarelto lawsuit, the womans husband was prescribed Xarelto in January 2012 to treat atrial fibrillation and suffered the subdural hemorrhage in June 2013.
\n\nAs Xarelto is developed to prevent clotting, there is a danger that excessive bleeding might continue till Xarelto has exited the patient’s method. For example, if there is bleeding near a vital organ such as the brain, lungs, or kidneys, then the typical blood flow to that organ could be interrupted. Xarelto carries a boxed warning stating that early/premature discontinuation of Xarelto increases the risk of thrombotic events If use of Xarelto is discontinued for any explanation besides problematic bleeding or the completion of therapy, patients are advised to strongly think about using a different anticoagulant medication.\n\nXarelto is prescribed to help minimize the risk of risk of stroke and blood clots in people with atrial fibrillation (not brought on by a heart valve issue) treat deep vein thrombosis and pulmonary embolism and to lessen the risk of forming a blood clot in the legs and lungs of folks who have just had knee or hip replacement surgery. But the drug could also cause irreversible internal bleeding that can lead to hospitalization and death.
\n\nAt the time they introduced the medication, Johnson & Johnson and Bayer buried mention about the lack of an Xarelto reversal agent in the full prescribing data, indicating that they did not test for all possible antidotes. Even following the link amongst Xarelto and serious bleeds became evident in post-advertising and marketing adverse event reports, the drug makers continued to market the medication as safe and effective, withholding data on the danger of irreversible bleeding. The lawyers at Saiontz & Kirk, P.A. are reviewing Xarelto situations for people throughout the United States.